| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PROSENSA HLDG N V SHS USD | 6,213,924 | 116,511,000 | 33.09% | ||
| 2 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 49,974,000 | 14.19% | ||
| 3 | SIENTRA INC | 2,199,012 | 36,877,000 | 10.47% | ||
| 4 | PORTOLA PHARMACEUTICALS INC | 930,682 | 26,357,000 | 7.49% | ||
| 5 | SUPERNUS PHARMACEUTICALS INC COM | 2,879,328 | 23,927,000 | 6.80% | ||
| 6 | LOMBARD MEDICAL INC | 3,473,452 | 22,056,000 | 6.26% | ||
| 7 | Proteon Therapeutics | 2,017,872 | 20,340,000 | 5.78% | ||
| 8 | Dicerna Pharmaceuticals | 1,182,196 | 19,423,000 | 5.52% | ||
| 9 | CEMPRA INC | 714,285 | 16,779,000 | 4.77% | ||
| 10 | AMARIN CORP PLC | 8,087,486 | 7,847,000 | 2.23% | ||
| 11 | REGULUS THERAPEUTICS INC | 327,350 | 5,247,000 | 1.49% | ||
| 12 | ZOGENIX INC | 2,335,218 | 3,176,000 | 0.90% | ||
| 13 | HYPERION THERAPEUTICS INC | 62,500 | 1,499,000 | 0.43% | ||
| 14 | OncoGenex Pharmaceuticals Inc | 603,740 | 1,352,000 | 0.38% | ||
| 15 | ANTHERA PHARMACEUTICALS I | 437,994 | 679,000 | 0.19% | ||
| 16 | Epirus Biopharma | 7,896 | 44,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-001866, filed 2015.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
